期刊文献+

强化治疗2型糖尿病应用甘精胰岛素与诺和灵N的临床观察

下载PDF
导出
摘要 目的:探讨强化治疗2型糖尿病控制高血糖的最佳方法。方法:64例经过口服药物控制不好的2型糖尿病患者,随机分组为甘精胰岛素治疗组(32例)与诺和灵N治疗组(32例),观察每组病人治疗前后各项临床指标变化。结果:甘精胰岛素治疗组空腹血糖和餐后2小时血糖所需胰岛素剂量、低血糖和黎明现象、血糖达标时间低于诺和灵N组。结论:甘精胰岛素是2型糖尿病强化治疗控制血糖的首选治疗方法。患者耐受性好,痛苦少,剂量调整灵活。
出处 《包头医学》 2009年第3期147-148,共2页 Journal of Baotou Medicine
  • 相关文献

参考文献3

  • 1Rosestock J, DAILEY G, massi - Benedetti M, et al. Reduced hypogylycemia risk with insulin glargine: a meta - analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005; 28(4): 950 -955.
  • 2Daves M, Storms F, Shutler s, et al. Improvement of glycemie control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005; 28(6): 1282 - 1288.
  • 3张良岩,李翠华,伊婕,杨乃龙.亚莫利分别与来得时、NPH联合治疗比较[J].实用糖尿病杂志,2006,2(6):16-17. 被引量:16

二级参考文献4

  • 1Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005,28(6):1282-1288.
  • 2Rosenstock J, Dailey G, Massi Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta - analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005,28(4) :950-955.
  • 3Mckeage K, Goa KL, Spotlight on insulin glargine in type 1 and 2 diabetes mellitus. Treat Endocrinol 2002, 1 (1) : 55 - 58.
  • 4Fonseca V, Bell DS, Berger S, et al. A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study. Am J Med Sci 2004,328(5) :274 - 280.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部